Work

The Hematopoietic Cell Transplant-Co-Morbidity Index (HCT-CI) Predicts Outcomes After T Cell Depleted (TCD) Allogeneic HCT For AML and MDS

Year: 2013

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v122.21.2045.2045

Authors: Ravin Ratan, Izaskun Ceberio, Patrick Hilden, Sean M. Devlin, Molly A Malloy, Juliet N Barker, Hugo Castro-Malaspina, Ann A. Jakubowski, Guenther Koehne, Esperanza B Papadopoulos, Doris M Ponce, Craig S. Sauter, Marcel R.M. van den Brink, James W. Young, Richard J. O'Reilly, Sergio Giralt, Jenna D Goldberg, Miguel-Angel Perales

Institutions: Memorial Sloan Kettering Cancer Center, Complejo Hospitalario de Navarra, Weill Cornell Medicine

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W85681482

FWCI: 0.717

Cites:

Cited by: 5

Related to: 10